Have a personal or library account? Click to login
Assessment of Neutrophil-to-Lymphocyte Ratio as A Prognostic Marker in Locally Advanced Head and Neck Cancer Treated with Concomitant Chemoradiation Cover

Assessment of Neutrophil-to-Lymphocyte Ratio as A Prognostic Marker in Locally Advanced Head and Neck Cancer Treated with Concomitant Chemoradiation

Forum of Clinical Oncology
Volume 13 (2022): Issue 3 (December 2022)
By: Elisha Servorip Targain,  Ashok Chauhan,  Diptajit Paul,  Shailley Arora Sehgal,  Abhishek Soni and  Paramjeet Kaur  
Open Access
|Oct 2023
DOI: https://doi.org/10.2478/fco-2023-0004 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 15 - 22
Submitted on: Mar 22, 2023
Accepted on: Jul 19, 2023
Published on: Oct 27, 2023
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Chemoradiation,
cisplatin,
head and neck cancer,
neutrophil-to-lymphocyte ratio,
prognosis
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2023 Elisha Servorip Targain, Ashok Chauhan, Diptajit Paul, Shailley Arora Sehgal, Abhishek Soni, Paramjeet Kaur, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 13 (2022): Issue 3 (December 2022)Next article